European Archives - Page 392 of 1053 - European Medical Journal

EMJ

Atopic Dermatitis: An Interactive Case

A highly engaging series of questions and exercises about a case of atopic dermatitis in a 10-month-old child patient.

EMJ

Wound Care: An Interactive Case

A highly engaging series of questions and exercises about wound care, starting from a case of an 83-year-old female patient with rheumatoid arthritis presenting with a toe lesion.

Supporting women with psoriasis: How can behavioural science help us?

This EMJ Podcast, hosted by Gemma Boak, research scientist and health advocate, explores how psychology can be used to optimise the management of treatment for women with psoriasis.

The emergence of digital twins

What is a digital twin and how do they benefit pharma?

Overlapping Clinical Manifestations of Multisystem Inflammatory Syndrome with Other Endemic Diseases

Multisystem inflammatory syndrome (MIS-C) is a challenging disease associated with COVID-19. Clinical manifestation of MIS-C may mimic many endemic illnesses of tropical and subtropical countries, making early diagnosis more difficult.

Going the extra mile for women's health

How can pharma boost R&D efforts into women’s health issues?

The Clock Is Ticking: The Imminent Need to Re-evaluate the Standard of Care in the 90-Day High-Risk Post-Acute Myocardial Infarction Period

The imminent need to re-evaluate the standard of care in the 90-day high-risk post-acute myocardial infarction period.

EMJ Cardiology 10 [Supplement 4] 2022

Speaking at the European Society of Cardiology (ESC) Congress 2021, Gabriel Steg and Kausik Ray discussed the residual risk of recurrent cardiovascular (CV) events that remains despite optimal standards of care for secondary prevention in the 90-day high-risk period after an acute myocardial infarction (AMI).

EMJ Hepatology 10 [Supplement 3] 2022

Several presentations at the recent International Liver Congress™ (ILC), held in London, UK, from 22nd–26th of June 2022, addressed the role of the gut microbiome in chronic liver disease.

Recent Findings in the Gut-Liver Axis and Associated Disease Therapy

Several presentations at the recent International Liver Congress™ (ILC), held in London, UK, from 22nd–26th of June 2022, addressed the role of the gut microbiome in chronic liver disease.